Leishmania donovani BPK282A1 complete genome, chromosome 17.
Eukaryota; Euglenozoa; Kinetoplastida; Trypanosomatidae; Leishmaniinae; Leishmania.
Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance
Submitted (30-MAR-2018) National Center for Biotechnology Information, NIH, Bethesda, MD 20894, USA
Submitted (25-JAN-2011) Aslett M., Pathogen Sequencing Unit, Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, Cambridgeshire CB10 1SA, UNITED KINGDOM
PROVISIONAL REFSEQ: This record has not yet been subject to final\nNCBI review. The reference sequence is identical to FR799604.\nData release policy http://www.sanger.ac.uk/legal/#t_2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: INSDC submitter\nAnnotation Status :: Full annotation\nAnnotation Pipeline :: Eukaryotic Annotation Propagation Pipeline\n##Genome-Annotation-Data-END##
mitogen-activated protein kinase kinase 3, putative
receptor-type adenylate cyclase, putative
NADH-ubiquinone oxidoreductase, mitochondrial, putative
bis(5'-nucleosyl)-tetraphosphatase, symmetrical-likeprotein
guanosine monophosphate reductase, putative
hydrolase, alpha/beta fold family-like protein
Short protein (LDBPK_081310, CBZ33263.1) was converted to a misc_feature.
3-oxo-5-alpha-steroid 4-dehydrogenase-like protein
myo-inositol-1(or 4)-monophosphatase 1, putative